MA
Mehmet Alp Atay
About Mehmet Alp Atay
Data last updated:
Mehmet Alp Atay is a Director at Astellas Pharma India Private Limited (since 2020). The company operates in Pharma. Astellas Pharma India Private Limited reported revenue of ₹68.97 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Astellas Pharma India Private Limited U85192MH2008FTC188194 | Director | 23 Jul 2020 | 2008 | ₹68.97 Cr (FY 2025) | Active |
Board colleagues of Mehmet Alp Atay
| Name | DIN | Company | Designation |
|---|---|---|---|
| Apurva Hemant Vinod | Astellas Pharma India Private Limited | Company Secretary | |
| Ricardo Fernando Bezerra Leite | 10471247 | Astellas Pharma India Private Limited | Director |
| Sampada Anandkumar Gosavi | 10046545 | Astellas Pharma India Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mehmet Alp Atay
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mehmet Alp Atay
Mehmet Alp Atay currently holds 1 directorship: Astellas Pharma India Private Limited (Director, since 23 Jul 2020, revenue ₹68.97 Cr (FY 2025)).
Mehmet Alp Atay was first appointed on 23 Jul 2020 as Director at Astellas Pharma India Private Limited.
The current boards of Mehmet Alp Atay's companies include Apurva Hemant Vinod (Astellas Pharma India Private Limited), Ricardo Fernando Bezerra Leite (Astellas Pharma India Private Limited), Sampada Anandkumar Gosavi (Astellas Pharma India Private Limited).